HPV相关口咽癌颈清扫淋巴结检出数对生存的影响
基于美国国家癌症数据库2010至2015年2554例T1-T2期HPV相关口咽鳞癌行原发灶切除及颈清扫的患者,按淋巴结检出数<26枚与≥26枚分层。校正协变量后,≥26枚与总生存无显著关联(HR 0.70,95%CI 0.49-1.00);在0-1枚病理阳性淋巴结患者中≥26枚与总生存改善显著相关(HR 0.29,95%CI 0.20-0.78),在≥2枚阳性淋巴结患者中该生存获益消失。
要点
- 全组中淋巴结检出≥26枚与总生存无显著关联(HR 0.70,95%CI 0.49-1.00)。
- 0-1枚病理阳性淋巴结者检出≥26枚与总生存改善显著相关(HR 0.29,95%CI 0.20-0.78)。
- 2-4枚阳性淋巴结者HR 0.89(95%CI 0.52-1.51),≥5枚者HR 1.01(95%CI 0.47-2.20),生存获益消失。
核心结论
- 对于手术治疗的早期T分期HPV相关口咽鳞癌,多发阳性淋巴结患者的淋巴结检出数与生存结局无关联。
- 区域转移负荷较有限(0-1枚阳性淋巴结)的患者,颈清扫中检出至少26枚淋巴结可能获益。
研究设计与样本
- 使用美国国家癌症数据库识别2010至2015年间接受原发灶切除及颈清扫的初治T1至T2期HPV相关口咽鳞癌患者。
- 共纳入2554例患者,按淋巴结检出数<26枚与≥26枚分层,采用多变量Cox比例风险回归分析总生存,模型按病理阳性淋巴结数目分层。
- 证据等级:4级。
主要发现
- 52%的患者有0至1枚病理阳性淋巴结。
- 全组中淋巴结检出≥26枚与生存无显著关联(HR 0.70,95%CI 0.49-1.00)。
- 0-1枚阳性淋巴结患者中,检出≥26枚与总生存改善显著相关(HR 0.29,95%CI 0.20-0.78)。
- 2-4枚阳性淋巴结患者中HR 0.89(95%CI 0.52-1.51),≥5枚阳性淋巴结患者中HR 1.01(95%CI 0.47-2.20)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the influence of nodal yield during neck dissection on survival in surgically managed human papillomavirus (HPV)-associated oropharyngeal cancer. METHODS: The National Cancer Database was used to identify patients with HPV-associated tumor T1 to T2 oropharyngeal squamous cell carcinoma who underwent upfront surgery with or without adjuvant therapy. Patients were stratified by lymph node yield (<26 vs. ≥26 nodes). Multivariable Cox proportional hazards regression analysis was used to identify factors associated with overall survival. Models were stratified by pathologically positive node number. RESULTS: There were 2,554 patients identified with previously untreated T1 to T2 oropharyngeal squamous cell carcinoma who underwent resection of the primary tumor and neck dissection between 2010 and 2015. Fifty-two percent had zero to one pathologically involved lymph node. Among all study patients, lymph node harvest of ≥26 was not associated with survival when adjusted for relevant covariates (hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.49-1.00). However, in patients with zero to one pathologically involved node, lymph node harvest of ≥26 was significantly associated with improved overall survival (HR 0.29, 95% CI 0.20-0.78). This survival benefit was lost in patients with two or more positive nodes (2-4 positive nodes: HR 0.89, 95% CI 0.52-1.51; 5 or more positive nodes: HR 1.01, 95% CI 0.47-2.20). CONCLUSION: For patients with surgically managed early T-stage HPV-associated oropharyngeal squamous cell carcinoma, lymph node yield was not associated with survival outcomes for patients with multiple positive lymph nodes. Those with a more limited burden of regional metastatic disease, however, may benefit harvest of at least 26 nodes during neck dissection. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:666-671, 2020.
引用
- Zenga J, Stadler M, Massey B, et al. Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer. Laryngoscope. 2019. PMID: 31206708. doi:10.1002/lary.28102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。